SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Burns A, Rosser M, Hecker J et al. The effects of donepezil in Alzheimer's disease: Results from a multinational trail. Dement Geriatr Cogn Disord 1999; 10: 237244.
  • 2
    Homma A, Takeda M, Imai Y et al. Clinical efficacy and safety of donepezil on coginitive and global function in patients with Alzheimer's disease: 24 week, multicenter, double-blind, placebo-controlled study in Japan. Dement Geriatr Cogn Disord 2000; 11: 299313.
  • 3
    Rogers SL, Doody RS, Prat RD, Ieni JR. Long term efficacy and safety of donepezil in the treatment of Alzheimer's desease: Final analysis of a US multicentre open-label study. Eur Neuropsychopharmacol 2000; 48: 195203.
  • 4
    Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Donepezil improves cognition and global function in Alzheimer's disease. Arch Neurol 1998; 158: 10211031.
  • 5
    Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24 week, double-blind,placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998; 50: 136145.
  • 6
    Rogers SL, Friedhoff LT. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: An interim analysis of the results of a US multicentre open label extension study. Eur Neuropsychopharmacol 1998; 8: 6775.
  • 7
    Tohgi H, Homma A, Imai Y et al. Long-term safety and efficacy of acetylcholinesterase inhibitor E2020 in patients with Alzheimer-type dementia: 52-week open label study. Rinsho Hyoka 2000; 28: 97126 (in Japanese).
  • 8
    Inoue J, Hoshino R, Nojima H, Okamoto N. Effects of donepezil hydrochloride on cognitive function in patients with Alzheimer-type dementia. Jpn J Geriatr Psychiatry 2007; 18: 9931002 (in Japanese).
  • 9
    Mckhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology 1984; 34: 939944.
  • 10
    Folstein MF, Folstein SE, McHugh PR. ‘Mini-Mental State’: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189198.
  • 11
    Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566572.
  • 12
    Panek PE, Wanger EE, Kennedy-Zwergel K. A review of projective test finding with older adults. J Pers Assess 1984; 47: 562582.
  • 13
    Hoshino R, Miyasato K, Okamoto N, Kondo N, Ohara K, Arima R. A comparative study of cognitive function in patients with senile dementia of Alzheimer-type and vascular dementia. Jpn J Geriatr Psychiatry 1994; 5: 6371 (in Japanese).
  • 14
    Hoshino R, Miyasato K, Okamoto N, Kondo N, Ohara K, Arima R. A study on the new Rorschach scale for evaluating cognitive function in aged person. Jpn J Geriatr Psychiatry 1996; 7: 409421 (in Japanese).
  • 15
    Courtney C, Farrell D, Gray R et al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial. Lancet 2004; 26: 21052115.